Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 2348485, 17 pages
https://doi.org/10.1155/2017/2348485
Research Article

Insulin-Like Growth Factor Binding Protein-6 Alters Skeletal Muscle Differentiation of Human Mesenchymal Stem Cells

Doaa Aboalola1,2,3,4 and Victor K. M. Han1,2,3,5

1Departments of Anatomy and Cell Biology, Western Ontario University, London, ON, Canada
2Children’s Health Research Institute, Western Ontario University, London, ON, Canada
3Lawson Health Research Institute, Western Ontario University, London, ON, Canada
4King Abdullah International Medical Research Center, National Guard Health Affairs, Jeddah, Saudi Arabia
5Departments of Paediatrics, Schulich School of Medicine & Dentistry, Western Ontario University, London, ON, Canada

Correspondence should be addressed to Victor K. M. Han; ac.no.cshl@nah.rotciv

Received 27 February 2017; Revised 7 July 2017; Accepted 19 July 2017; Published 14 September 2017

Academic Editor: Sari Pennings

Copyright © 2017 Doaa Aboalola and Victor K. M. Han. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. Anker, S. Sa, C. K. Van der Keur et al., “Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta,” Stem Cells, vol. 22, pp. 1338–1345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Fukuchi, H. Nakajima, D. Sugiyama, I. Hirose, T. Kitamura, and K. Tsuji, “Human placenta-derived cells have mesenchymal stem/progenitor cell potential,” Stem Cells, vol. 22, pp. 649–658, 2004. View at Publisher · View at Google Scholar
  3. Z. Miao, J. Jin, L. Chen et al., “Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells,” Cell Biology International, vol. 30, pp. 681–687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Buckingham, “Skeletal muscle progenitor cells and the role of pax genes,” Comptes Rendus Biologies, vol. 330, pp. 530–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rudnicki, “Marrow to muscle, fission versus fusion,” Nature Medicine, vol. 9, no. 12, pp. 1461-1462, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Engler, S. Sen, H. L. Sweeney, and D. E. Discher, “Matrix elasticity directs stem cell lineage specification,” Cell, vol. 126, pp. 677–689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. M. Gilbert, K. L. Havenstrite, K. E. Magnusson et al., “Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture,” Science, vol. 329, pp. 1078–1081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Di Rocco, M. G. Iachininoto, A. Tritarelli et al., “Myogenic potential of adipose-tissue-derived cells,” Journal of Cell Science, vol. 119, pp. 2945–2952, 2006. View at Google Scholar
  10. E. J. Gang, R. Darabi, D. Bosnakovski et al., “Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery,” Experimental Cell Research, vol. 315, pp. 2624–2636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. I. Jones and D. R. Clemmons, “Insulin-like growth factors and their binding proteins: biological actions,” Endocrine Reviews, vol. 16, pp. 3–34, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. W. S. Cohick and D. R. Clemmons, “The insulin-like growth factors,” Annual Review of Physiology, vol. 55, pp. 131–153, 1993. View at Publisher · View at Google Scholar
  13. S. Shimasaki and N. Ling, “Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6),” Progress in Growth Factor Research, vol. 3, pp. 243–266, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. L. A. Bach, S. J. Headey, and R. S. Norton, “IGF-binding proteins-the pieces are falling into place,” Trends in Endocrinology and Metabolism, vol. 16, pp. 228–234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Bach, S. Hsieh, K. Sakano, H. Fujiwara, J. F. Perdue, and M. M. Rechler, “Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6,” The Journal of Biological Chemistry, vol. 268, pp. 9246–9254, 1993. View at Google Scholar
  16. L. A. Bach, “IGFBP-6 five years on; not so ‘forgotten’?” Growth Hormone & IGF Research, vol. 15, pp. 185–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Bach, P. Fu, and Z. Yang, “Insulin-like growth factor-binding protein-6 and cancer,” Clinical Science, vol. 124, pp. 215–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. B. Janosi, P. A. Ramsland, M. R. Mott, S. M. Firth, R. C. Baxter, and P. J. Delhanty, “The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes structural determination by molecular modeling and electron microscopy,” The Journal of Biological Chemistry, vol. 274, pp. 23328–23332, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Iosef, G. Vilk, T. Gkourasas et al., “Insulin-like growth factor binding protein 6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate DNA repair and apoptosis,” Journal of Cell Science, vol. 22, pp. 1033–1043, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. Liu, J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis, “Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r),” Cell, vol. 75, no. 1, pp. 59–72, 1993. View at Publisher · View at Google Scholar
  21. L. Powell-Braxton, P. Hollingshead, C. Warburton et al., “IGF-I is required for normal embryonic growth in mice,” Genes & Development, vol. 7, pp. 2609–2617, 1993. View at Publisher · View at Google Scholar
  22. N. Zanou and P. Gailly, “Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathway,” Cellular and Molecular Life Sciences, vol. 70, pp. 4117–4130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Iosef, T. Gkourasas, C. Y. Jia, S. S. Li, and V. K. Han, “A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import,” Endocrinology, vol. 149, pp. 1214–1226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. G. Worton, E. A. McCulloch, and J. E. Till, “Physical separation of hemopoietic stem cells from cells forming colonies in culture,” Journal of Cellular Physiology, vol. 74, pp. 171–182, 1969. View at Publisher · View at Google Scholar · View at Scopus
  25. B. J. Capoccia, D. L. Robson, K. D. Levac et al., “Revascularization of ischemic limbs by human bone marrow cells purified by aldehyde dehydrogenase activity,” Blood, vol. 113, no. 21, pp. 5340–5351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. M. Putman, K. Y. Liu, H. C. Broughton, G. I. Bell, and D. A. Hess, “Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury,” Stem Cells, vol. 30, no. 10, pp. 2248–2260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Mimeault and S. K. Batra, “Recent progress on tissue-resident adult stem cell biology and their therapeutic implications,” Stem Cell Reviews, vol. 4, no. 1, pp. 27–49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. E. R. Andersson and U. Lendahl, “Regenerative medicine: a 2009 overview,” Journal of Internal Medicine, vol. 266, no. 4, pp. 303–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail, “Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells,” Stem Cells, vol. 24, pp. 462–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Péault, M. Rudnicki, Y. Torrente et al., “Stem and progenitor cells in skeletal muscle development, maintenance, and therapy,” Molecular Therapy, vol. 15, no. 5, pp. 867–877, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Meregalli, A. Farini, M. Belicchi et al., “Perspectives of stem cell therapy in Duchenne muscular dystrophy,” FEBS Journal, vol. 10, pp. 1111–12083, 2012. View at Google Scholar
  32. O. Parolini, F. Alviano, G. P. Bagnara et al., “Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells,” Stem Cells, vol. 26, no. 2, pp. 300–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. B. Koh and G. Suck, “Cell therapy: promise fulfilled?” Biologicals: Journal of the International Association of Biological Standardization, vol. 40, no. 3, pp. 214–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D. C. Ding, W. C. Shyu, and S. Z. Lin, “Mesenchymal stem cells,” Cell Transplantation, vol. 20, no. 1, pp. 5–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Musaro, K. McCullagh, A. Paul et al., “Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle,” Nature Genetics, vol. 27, pp. 195–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Musaro, C. Giacinti, G. Borsellino et al., “Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, pp. 1206–1210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Gehmert, C. Wenzel, M. Loibl et al., “Adipose tissue-derived stem cell secreted IGF-1 protects myoblasts from the negative effect of myostatin,” BioMed Research International, vol. 2014, Article ID 129048, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Grimberg and P. Cohen, “Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis,” Journal of Cellular Physiology, vol. 183, pp. 1–9, 2000. View at Publisher · View at Google Scholar
  39. H. Ren, P. Yin, and C. Duan, “IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop,” The Journal of Cell Biology, vol. 182, no. 5, pp. 979–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. L. A. Silverman, Z. Q. Cheng, D. Hsiao, and S. M. Rosenthal, “Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells,” Endocrinology, vol. 136, no. 2, pp. 720–726, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Putzer, P. Breuer, W. Gotz et al., “Mouse insulin-like growth factor binding protein-6: expression, purification, characterization and histochemical localization,” Molecular and Cellular Endocrinology, vol. 137, pp. 69–78, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Raykha, J. Crawford, B. S. Gan, P. Fu, L. A. Bach, and D. B. O'Gorman, “IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren’s disease,” Biochimica et Biophysica Acta, vol. 2013, pp. 1511–1519, 1832. View at Publisher · View at Google Scholar · View at Scopus
  43. P. J. Delhanty, D. J. Hill, S. Shimasaki, and V. K. Han, “Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation?” Growth Regulation, vol. 3, no. 1, pp. 8–11, 1993. View at Google Scholar
  44. V. K. Han, N. Bassett, J. Walton, and J. R. Challis, “The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface,” The Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 7, pp. 2680–2693, 1996. View at Publisher · View at Google Scholar
  45. L. A. Bach, S. Hsieh, A. L. Brown, and M. M. Rechler, “Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts,” Endocrinology, vol. 135, pp. 2168–2176, 1994. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Rubin and R. Baserga, “Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity,” Laboratory Investigation, vol. 73, pp. 311–331, 1995. View at Google Scholar
  47. S. Jiao, Y. Li, J. Zhou, and L. Lu, “Differential regulation of IGF-I and IGF-II gene expression in skeletal muscle cells,” Molecular and Cellular Biochemistry, vol. 373, pp. 107–113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Wang, Y. Liu, C. Wu et al., “The expression of IGFBP6 after spinal cord injury: implications for neuronal apoptosis,” Neurochemical Research, vol. 42, no. 2, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. L. A. Bach, “Current ideas on the biology of IGFBP-6: more than an IGF-II inhibitor?” Growth Hormone & IGF Reserch, vol. 30-31, pp. 81–86, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Aboalola, “Building muscle: the role of insulin-like growth factor binding protein-6 and insulin-like growth factors in the differentiation of placental mesenchymal stem cells into skeletal muscle,” 2017, Electronic Thesis and Dissertation Repository, 4557. View at Google Scholar